SOURCE: Novo Nordisk A/S

August 04, 2008 08:20 ET

Novo Nordisk A/S -- Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - August 4, 2008) - Novo Nordisk A/S - Share repurchase programme


On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 2 billion in the period from 31 January 2008 to 6 August 2008.

Since the announcement as of 28 July 2008, the following transactions have been made under the programme:

                  Number of    Average      Transaction
                   shares   purchase price  value, DKK
Accumulated, last 5,805,407                1,845,247,099
announcement
28 July 2008         50,000       295.6400    14,782,000
29 July 2008         60,000       296.2300    17,773,800
30 July 2008         60,000       299.6100    17,976,600
31 July 2008         60,000       302.1200    18,127,200
01 August 2008       60,000       309.1500    18,549,000
Accumulated, 2008 6,095,407                1,932,455,699

With the transactions stated above, Novo Nordisk owns a total of 17,798,930 treasury shares, corresponding to 2.8% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Outside North America: Mads Veggerby Lausten
Elin K Hansen          Tel: (+45) 4443 7919
Tel: (+45) 4442 3450   mlau@novonordisk.com
ekh@novonordisk.com
                       Hans Rommer
In North America:      Tel: (+45) 4442 4765
Sean Clements          hrmm@novonordisk.com
Tel: (+1) 609 514 8316
secl@novonordisk.com

Stock Exchange Announcement no 48 / 2008





Copyright © Hugin AS 2008. All rights reserved.

Contact Information